135 related articles for article (PubMed ID: 16387680)
1. Curcumin inhibits the classical and the alternate pathways of complement activation.
Kulkarni AP; Ghebremariam YT; Kotwal GJ
Ann N Y Acad Sci; 2005 Nov; 1056():100-12. PubMed ID: 16387680
[TBL] [Abstract][Full Text] [Related]
2. Humanized recombinant vaccinia virus complement control protein (hrVCP) with three amino acid changes, H98Y, E102K, and E120K creating an additional putative heparin binding site, is 100-fold more active than rVCP in blocking both classical and alternative complement pathways.
Ghebremariam YT; Odunuga OO; Janse K; Kotwal GJ
Ann N Y Acad Sci; 2005 Nov; 1056():113-22. PubMed ID: 16387681
[TBL] [Abstract][Full Text] [Related]
3. Clionasterol: a potent inhibitor of complement component C1.
Cerqueira F; Watanadilok R; Sonchaeng P; Kijjoa A; Pinto M; Quarles van Ufford H; Kroes B; Beukelman C; Nascimento MS
Planta Med; 2003 Feb; 69(2):174-6. PubMed ID: 12624828
[TBL] [Abstract][Full Text] [Related]
4. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
Nielsen EW; Waage C; Fure H; Brekke OL; Sfyroera G; Lambris JD; Mollnes TE
Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176
[TBL] [Abstract][Full Text] [Related]
5. The inhibitory effect of rosmarinic acid on complement involves the C5 convertase.
Peake PW; Pussell BA; Martyn P; Timmermans V; Charlesworth JA
Int J Immunopharmacol; 1991; 13(7):853-7. PubMed ID: 1761351
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of complement by gold sodium thiomalate.
Hasselbacher P
J Rheumatol; 1981; 8(1):57-61. PubMed ID: 6783754
[TBL] [Abstract][Full Text] [Related]
7. Action of a new non-steroid anti-inflammatory drug, carprofen (Ro 20-5720) on activation of the complement system: an in vitro research.
Auteria A; Laghi Pasini F; Di Perri T
Int J Tissue React; 1982; 4(1):9-13. PubMed ID: 7085003
[TBL] [Abstract][Full Text] [Related]
8. Effect of some hydroxycoumarins on complement-mediated hemolysis in human serum.
Ivanovska N; Yossifova T; Vassileva E; Kostova I
Methods Find Exp Clin Pharmacol; 1994 Oct; 16(8):557-62. PubMed ID: 7760580
[TBL] [Abstract][Full Text] [Related]
9. Complement-inhibiting iridoids from Morinda morindoides.
Cimanga K; Hermans N; Apers S; Van Miert S; Van den Heuvel H; Claeys M; Pieters L; Vlietinck A
J Nat Prod; 2003 Jan; 66(1):97-102. PubMed ID: 12542353
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of equine complement activity by polysulfated glycosaminoglycans.
Rashmir-Raven AM; Coyne CP; Fenwick BW; Gaughan EM; Andrews GA; DeBowes RM
Am J Vet Res; 1992 Jan; 53(1):87-90. PubMed ID: 1539920
[TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum.
Walpen AJ; Laumonier T; Aebi C; Mohacsi PJ; Rieben R
Xenotransplantation; 2004 Mar; 11(2):141-8. PubMed ID: 14962276
[TBL] [Abstract][Full Text] [Related]
12. Anti-complement effects of lactoferrin-derived peptides.
Samuelsen Ø; Haukland HH; Ulvatne H; Vorland LH
FEMS Immunol Med Microbiol; 2004 Jun; 41(2):141-8. PubMed ID: 15145458
[TBL] [Abstract][Full Text] [Related]
13. Anticomplement activity of polyacetylenes from leaves of Dendropanax morbifera Leveille.
Chung IM; Song HK; Kim SJ; Moon HI
Phytother Res; 2011 May; 25(5):784-6. PubMed ID: 21520473
[TBL] [Abstract][Full Text] [Related]
14. Isolated compounds from Sorghum bicolor L. inhibit the classical pathway of the complement.
Moon HI; Lee YC; Lee JH
Immunopharmacol Immunotoxicol; 2012 Apr; 34(2):299-302. PubMed ID: 21854169
[TBL] [Abstract][Full Text] [Related]
15. Oxiagin from the Naja oxiana cobra venom is the first reprolysin inhibiting the classical pathway of complement.
Shoibonov BB; Osipov AV; Kryukova EV; Zinchenko AA; Lakhtin VM; Tsetlin VI; Utkin YN
Mol Immunol; 2005 Jun; 42(10):1141-53. PubMed ID: 15829304
[TBL] [Abstract][Full Text] [Related]
16. In vitro inhibition of the classical and alternate pathways of activation of human complement by N acetyl aspartyl glutamic acid (NAAGA).
Etievant M; Leluc B; David B
Agents Actions; 1988 Jun; 24(1-2):137-44. PubMed ID: 3261498
[TBL] [Abstract][Full Text] [Related]
17. [Modification of proteolytic complement cascade after treatment with exogenous heparin].
Galebskaia LV; Solovtsova IL; Riumina EV
Vopr Med Khim; 2001; 47(1):91-7. PubMed ID: 11386002
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the classical and alternative pathways of the human complement system by glycosaminoglycan polysulfate.
de Messias IT; Mohren D; Kajdacsy-Balla A
J Investig Allergol Clin Immunol; 1994; 4(4):172-6. PubMed ID: 7850029
[TBL] [Abstract][Full Text] [Related]
19. Anti- and pro-oxidant effects of oxidized quercetin, curcumin or curcumin-related compounds with thiols or ascorbate as measured by the induction period method.
Fujisawa S; Kadoma Y
In Vivo; 2006; 20(1):39-44. PubMed ID: 16433026
[TBL] [Abstract][Full Text] [Related]
20. Anticomplement activity of lysine complexes of propolis phenolic constituents and their synthetic analogs.
Georgieva P; Ivanovska N; Bankova V; Popov S
Z Naturforsch C J Biosci; 1997; 52(1-2):60-4. PubMed ID: 9090067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
